Lonza Expanding Swiss Microbial Operations
Lonza Expanding Swiss Microbial Operations
GALWAY, IRELAND--December 7, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--Swiss contract development and manufacturing organization (CDMO) Lonza Group (Basel, Switzerland) is planning a 50% boost in production capacity and laboratory space at its microbial operations in Visp, Switzerland.
Within this article: Details Visp plant expansion, planned additions, related projects, Moderna COVID-19 contracts
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- EU and AstraZeneca Strike Deal to End Vaccine Row
- Lonza Building New Swiss Plant, Expands Moderna COVID-19 Manufacturing Deal
- Europe Clears Extra COVID-19 Manufacturing Sites to Boost Supplies
- 'Ark-La-Tex' Life Science Market Off to a Robust Start With $3.1 Billion In...
- EU Adds New COVID-19 Manufacturing Capacity